GSK shares have risen 6% or 89p to 1469p after the drugs giant improved its long-term sales guidance alongside 2024 annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback